Article Details
Retrieved on: 2021-04-01 17:15:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Kamada has reported top-line results from its Phase I/II clinical trial of anti-SARS-CoV-2 plasma-derived hyperimmune globulin (IgG) treating ...
Article found on: www.clinicaltrialsarena.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here